Paper - WANFANG MED ONLINE

You Position: Home > Paper

2019 Chinese practice guideline for prevention and treatment of hepatitis B virus mother-to-child transmission

( views:90, downloads:1168 )

Author:: No author available

Journal Title:: Chinese Journal of Clinical Infectious Diseases

Issue:: 5

DOI:: 10.3760/cma.j.issn.1674-2397.2019.05.001

Key Word:: 肝炎,乙型;母婴传播;指南;中国;Hepatitis B;Mother to child transmission;Guideline;China

Abstract：阻断母婴传播是消除乙型肝炎病毒(Hepatitis B virus,HBV)感染的关键环节.由中华医学会感染病学分会发起,联合多学科专家,基于系统评价证据,结合患者意愿,采用GRADE分级,遵循RIGHT报告标准,制订我国首部循证HBV母婴传播防治指南,以期为临床医师和妇幼保健相关人员提供围产期监测、干预及新生儿免疫的决策依据.

Reference

[1]中国肝炎防治基金会,中华医学会感染病学分会,中华医学会肝病学分会.乙型肝炎母婴阻断临床管理流程[J].2017,(7).
[2]黄慧.不同喂养方式对乙型肝炎病毒感染产妇母婴传播的影响[J].2019,(4).
[3]柳榴,刘倩,文妍琪,等.不孕妇女乙肝病毒感染者的卵巢储备功能研究[J].2016,(1).
[4]王晓晓,鲁俊峰,武亚丽,等.慢性HBV携带孕妇妊娠期及产后肝功能、病毒学、血清学变化及停药安全性的临床研究[J].2019,(4).
[5]李桃源,何京,卢永平,等.羊膜腔穿刺对母婴HBV垂直传播的meta分析[J].2017,(3).
[6]中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南（2015更新版）[J].2015,(11).
[7]蒋朱明,詹思延,贾晓巍,等.制订/修订《临床诊疗指南》的基本方法及程序[J].2016,(4).
[8]Hanna SE,Grimshaw J,Graham ID,etc.AGREE II: advancing guideline development, reporting, and evaluation in health care.[J].2010,51(5).
[9]Giuseppe,Indolfi,Philippa,Easterbrook,Geoffrey,Dusheiko,etc.Hepatitis B virus infection in children and adolescents.[J].2019.
[10]Adolfo, Correa,Janet D, Cragan,James E, Kucik,etc.Reporting birth defects surveillance data 1968-2003.[J].2007,79(2).
[11]林津,沙艳伟,邱乒乒,等.乙肝病毒携带对不同卵巢储备功能女性体外受精-胚胎移植结局的影响[J].2017,(2).
[12]Guyatt G,Oxman AD,Akl EA,etc.GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.[J].2011,64(4).
[13]Hui-Lian, Wang,Xi, Lu,Xudong, Yang,etc.Antiviral Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients: A Systematic Review and Network Meta-Analysis.[J].2016.
[14]Kenneth K, Mugwanya,Craig W, Hendrix,Nelly R, Mugo,etc.Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.[J].2016,(9).
[15]Yi, Wei,Pan, Calvin Q.,Li, Ming-Hui,etc.The characteristics and predictors of postpartum hepatitis flares in women with chronic hepatitis B[J].2018,113(5).
[16]A, Montoya-Ferrer,A M, Zorrilla,J, Viljoen,etc.High Level of HBV DNA Virus in the Breast Milk Seems not to Contraindicate Breastfeeding.[J].2015,7(1).
[17].EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection[J].2017,67(2).
[18]Mouchli, Mohamed A.,Wong, John B.,Ahmed, Ahmed T.,etc.Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis[J].2016,63(1).
[19]张淑萍,李宝来,王欣.产妇合并不同HBV感染模式产后血清、唾液及乳汁HBV-DNA载量测定的意义及相关性分析[J].2019,(9).
[20]Pan, Calvin Q.,Duan, Zhongping,Dai, Erhei,etc.Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load[J].2016,374(24).
[21]Kyohaire, Isabella,Owen, Andrew,Khoo, Saye,etc.Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs[J].2018,73(4).
[22]Jourdain, G.,Ngo-Giang-Huong, N.,Harrison, L.,etc.Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B[J].2018,378(10).
[23]Wang CM,Bai SF,Zhao W,etc.A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.[J].2011,55(6).
[24]P K Coyle,S M Sinclair,A E Scheuerle,etc.Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events[J].2014,4(5).
[25]Hellwig, Kerstin,Langer-Gould, Annette,Queisser-Wahrendorf, Annette,etc.Interferon-beta exposure during first trimester is safe in women with multiple sclerosisA prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry[J].2016,22(6).
[26]Kazuya Sakai,Akane Ueda,Masaaki Hasegawa,etc.Efficacy and safety of interferon alpha for essential thrombocythemia during pregnancy: two cases and a literature review[J].2018,108(2).
[27]Wang, Jing,Liu, Jinfeng,Qi, Caijing,etc.Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudine-resistant HBV[J].2015,20(7).
[28]C W N, Spearman,M W, Sonderup,J F, Botha,etc.South African guideline for the management of chronic hepatitis B: 2013.[J].2013,103.
[29]Giles, Michelle,Visvanathan, Kumar,Lewin, Sharon,etc.Clinical and virological predictors of hepatic flares in pregnant women with chronic hepatitis B[J].2015,64(11).
[30]Sandberg Wollheim M,Moraga MS,Alteri E,etc.Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy.[J].2011,17(4).
[31]Romero, Rebecca S.,Luenzmann, Claudia,Bugge, Joeerg-Peter.Pregnancy outcomes in patients exposed to interferon beta-1b[J].2015,86(5).
[32]Schünemann, Holger J.,Wiercioch, Wojtek,Etxeandia, Itziar,etc.Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise.[J].2014,186(3).
[33]Tian, Zhen,Tang, Xianmei,Cao, Furong,etc.Baseline Hepatitis B Virus Titer Predicts Initial Postpartum Hepatic Flare A Multicenter Prospective Study[J].2018,52(10).
[34]Beauverd, Yan,Radia, Deepti,Cargo, Catherine,etc.Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series[J].2016,101(5).
[35]Tianyan, Chen,Jing, Wang,Yuling, Feng,etc.Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?[J].2013,13.
[36]凌寒.卫生部发布《中国出生缺陷防治报告（2012）》[J].2012,(28).
[37]A, Obayashi,K, Okochi,M, Mayumi.Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer.[J].1972,62(4).
[38]Chang, Christine Y.,Aziz, Natali,Poongkunran, Mugilan,etc.Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B[J].2016,111(10).
[39].Pharmacokinetics and safety of tenofovir in hiv-infected women during labor and their infants during the first week of life[J].2014,65(1).
[40]俞健梅.女性HBV感染对体外受精-胚胎移植结局的影响[D].2015.
[41]Halil Ibrahim Atasoy,Pinar Sirmatel,Fatma Sirmatel.Pegylated interferon therapy during early pregnancy for hepatitis B infection: does it prevent vertical transmission?[J].2016,(6).
[42]Ji,Y.,Jiang,Q.,Yu,M.,etc.The efficacy and safety of antiviral therapy with lamivudine to stop the vertical transmission of hepatitis B virus[J].2012,31(9).
[43]Tran, Tram T.,Ahn, Joseph,Reau, Nancy S..ACG Clinical Guideline: Liver Disease and Pregnancy[J].2016,111(2).
[44]Yang,Y.,Jin,L.,He,Y.-L.,etc.Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China[J].2013,85(11).
[45]Terrault Norah A.,Lok Anna S.F.,McMahon Brian J.,etc.Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance[J].2018,67(4).
[46]Hiratsuka M,Minakami H,Koshizuka S,etc.Administration of interferon-alpha during pregnancy: effects on fetus.[J].2000,28(5).
[47]Jing Wang,Yingli He,Dongfang Jin,etc.No response to hepatitis B vaccine in infants born to HBsAg(+) mothers is associated to the transplacental transfer of HBsAg[J].2017,49(8).
[48]Labarga P,Cachorro I,del-Prado YR,etc.Infant of 22 months of age with no anomalies born from a HCV- and HIV-infected mother under treatment with pegylated interferon, ribavirin and antiretroviral therapy during the first 16 weeks of pregnancy.[J].2007,24(3).